GlassScriptPhysician profile
Margaret Henninger
NPI 1093357386
$4,667.12
in general payments reported to CMS, 2019-2025
22 companies · $3,720 in 2025
The $3,720 reported for 2025 was more than what 97% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.24 · 2022: $120 · 2023: $442 · 2024: $372 · 2025: $3,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,275 · Travel and Lodging: $2,160 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,274.99 |
| Travel and Lodging | $2,160.06 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $1,643.85 | 2025 | Barostim Neo System |
| Abbott Laboratories | $1,503.64 | 2024-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $493.72 | 2022-2025 | Camzyos |
| Takeda Pharmaceuticals U.S.A., INC. | $149.70 | 2023-2024 | Livtencity |
| Actelion Pharmaceuticals US, INC. | $148.72 | 2024-2025 | Uptravi, Opsumit, Opsynvi |
| Merck Sharp & Dohme LLC | $141.98 | 2023-2025 | Verquvo, Winrevair |
| United Therapeutics Corporation | $124.99 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.99 | 2024-2025 | |
| Eurofins Viracor, LLC | $57.97 | 2025 | |
| Impulse Dynamics (USA) INC. | $45.09 | 2023-2024 | Optimizer, Optimizer |
| Bridgebio Pharma, INC. | $33.99 | 2025 | Attruby |
| Pfizer INC. | $33.17 | 2022-2025 | |
| Atricure, INC. | $28.84 | 2025 | Atriclip Laa Exclusion System |
| Irhythm Technologies, INC. | $28.61 | 2024 | Zio Xt Patch, Zio Monitor |
| Ancora Heart, INC. | $28.15 | 2024 | Accucinch |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endotronix, INC. | $27.37 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Astrazeneca Pharmaceuticals LP | $26.03 | 2021-2023 | |
| Melinta Therapeutics, LLC | $20.73 | 2025 | Rezzayo |
| Novartis Pharmaceuticals Corporation | $20.37 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.88 | 2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.65 | 2025 | |
| Kestra Medical Technology Services, INC. | $13.68 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Henninger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.